Alnylam Pharmaceuticals, Inc. (BVMF:A1LN34)
Brazil flag Brazil · Delayed Price · Currency is BRL
83.44
-0.06 (-0.07%)
At close: Mar 17, 2026

Alnylam Pharmaceuticals Ratios and Metrics

Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
218,807279,694161,656127,937156,484108,290
Market Cap Growth
18.23%73.02%26.36%-18.24%44.51%34.68%
Enterprise Value
219,126270,791154,003121,691151,627100,434
PE Ratio
126.62170.67-107.94-54.38-25.55-23.55
Forward PE
31.4260.03----
PS Ratio
10.7014.1713.5313.1728.3924.14
PB Ratio
50.3466.70453.50-109.13-186.1334.65
P/TBV Ratio
14.2467.86447.73-108.36-182.7834.15
P/FCF Ratio
85.36113.11-714.37574.04-48.02-28.38
P/OCF Ratio
75.80100.44-3660.27231.17-54.41-31.76
EV/Sales Ratio
11.1613.7212.8912.5327.5122.39
EV/EBITDA Ratio
65.6491.46-241.10-100.40-38.53-28.59
EV/EBIT Ratio
82.66101.61-163.86-81.16-36.35-26.67
EV/FCF Ratio
85.48109.51-680.55546.02-46.53-26.32
Debt / Equity Ratio
1.561.5618.69-5.73-8.081.63
Debt / EBITDA Ratio
2.292.29-10.78-5.72-1.78-1.51
Debt / FCF Ratio
2.752.75-30.4331.12-2.15-1.39
Net Debt / Equity Ratio
-2.07-2.07-20.845.145.51-2.44
Net Debt / EBITDA Ratio
-2.92-2.9211.634.971.182.17
Net Debt / FCF Ratio
-3.50-3.5032.84-27.031.422.00
Asset Turnover
0.810.810.560.500.290.24
Inventory Turnover
8.468.463.862.851.571.73
Quick Ratio
2.512.512.612.863.163.79
Current Ratio
2.762.762.783.083.514.04
Return on Equity (ROE)
131.93%73.28%362.29%232.40%-526.14%-106.31%
Return on Assets (ROA)
10.58%10.58%-3.23%-7.77%-21.92%-20.12%
Return on Invested Capital (ROIC)
63.85%63.85%-20.29%-43.01%-108.72%-76.10%
Return on Capital Employed (ROCE)
15.31%15.31%-5.98%-10.01%-27.42%-24.57%
Earnings Yield
0.79%0.59%-0.93%-1.84%-3.91%-4.25%
FCF Yield
1.17%0.88%-0.14%0.17%-2.08%-3.52%
Buyback Yield / Dilution
-0.47%-0.47%-1.00%-0.61%-0.88%-1.21%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.